Cellyan Biotechnology Co., Ltd cash flow statement HKPD
In fiscal 2025, which ended Mar 31, 2025, Cellyan Biotechnology Co., Ltd generated $569,214 of cash from operations. It spent $69,916 on capital expenditures. That left free cash flow of $499,298.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2025
Mar 31, 2025
|
|---|---|
| Operating | |
| Depreciation and amortization |
0
|
| Operating cash flow |
1
|
| Investing | |
| Capital expenditures |
0
|
| Investing cash flow |
-2
|
| Financing | |
| Debt issued |
1
|
| Debt repaid |
0
|
| Financing cash flow |
2
|
| Change in cash | |
| Effect of exchange rate |
0
|
| Net change in cash |
0
|
| Free cash flow |
0
|
| Per share | |
| Free cash flow per share |
0.05
|
| Ratios | |
| Free cash flow margin |
2.46%
|
| Capital expenditures to revenue |
0.34%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- HKPD (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Cayman Islands
- Headquarters
- Kowloon
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2007702
- Former names
- Hong Kong Pharma Digital Technology Holdings Ltd (until Dec 17, 2025)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.